Interrogation of the TCGA-PAAD cohort2 for mutations and CNAs revealed frequent heterozygous loss for genes implicated in DDR, particularly for BAP1 (29%), CHEK2 (29%), and RAD51C (27.7%) (Fig. 1a). Here, BAP1 is linked to pancreatic adenocarcinoma.